MEDIMMUNE INC.

* * * * * * * * * * DESCRIPTION * * * * * * * * * *
MedImmune helps babies breathe easier. Its flagship product, Synagis, prevents respiratory syncytial virus (RSV), a major cause of pneumonia and other respiratory disease in infants and children. Also on the market are FluMist, its nasal spray flu vaccine; Ethyol, which treats side effects of chemotherapy and radiation; and Neutrexin, a treatment for a kind of pneumonia that often afflicts AIDS patients. The company has drugs in development for treating infectious diseases, cancer, and inflammatory conditions. MedImmune sold CytoGam, which treats cytomegalovirus in organ transplant patients, to CSL Behring in 2006.RETURN

GENERAL MOTORS

* * * * * * * * * * DESCRIPTION * * * * * * * * * *



Although more than 50 years old, GM Nameplate still likes to play tag. The company makes product identification components, injection molded plastics, and electronic input devices. End products include decals, labels, mouse pads, and tags, as well as electronic components such as keypads and switching assemblies. GM Nameplate serves the rapidly changing needs of businesses from FORTUNE 500 companies to start-ups, complementing the internal resources of its customers, enabling them to launch their products to market faster. Customers include Boeing, Dell, General Electric, General Motors, Microsoft, and Xerox. GM Nameplate has five plants in the US, and one each in Canada, China, and Singapore.